Logo image
Postpartum women and selective serotonin reuptake inhibitors (SSRIs)
Presentation   Open access

Postpartum women and selective serotonin reuptake inhibitors (SSRIs)

Bethany Faucett, Krysanne Hagen, Payton Herring, Abby Webb and Jackie Wells
University of West Florida Libraries
Integration of Evidence in Professional Nursing Practice Research Presentations, Research presentations (School of Nursing, Usha Kundu College of Health, University of West Florida, Pensacola, Florida, 2022)
2022

Metrics

30 File views/ downloads
370 Record Views

Abstract

Postpartum depression (PPD) is a common disorder that happens after a woman has given girth. The ramifications of PPD can have short or long-term effects on the mother, child, and the family as a whole (Brown et al., 2021). Selective serotonin reuptake inhibitor (SSRI) use in postpartum women has been controversial for many years due to the potential effects to the infant through lactation. There has been an increase of 2.3% of SSRI use in the postpartum phase in the last 20 years (Molenaar et al., 2019).
mp4
Postpartum women and selective serotonin reuptake inhibitors (SSRIs)41.46 MBDownloadView
Presentationmp4 Open Access

Related links

Details

Logo image